Virus-free transfer of the herpes simplex virus thymidine kinase gene followed by ganciclovir treatment induces tumor cell death

Clinical Cancer Research

Volumn 2, Issue 1, 1996, Pages 47-51

  Calvez, V ^a,b   Rixe, O ^a   Wang, P ^a   Mouawad, R ^a   Soubrane, C ^a   Ghoumari, A ^a   Verola, O ^c   Khayat, D ^a   Colbere Garapin F ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSTITUT PASTEUR   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

ANIMAL CELL; ARTICLE; CELL DEATH; CONTROLLED STUDY; GENE TRANSFER; HERPES SIMPLEX VIRUS; MELANOMA B16; MOUSE; PRIORITY JOURNAL;

ANIMALS; CELL DEATH; GANCICLOVIR; GENE THERAPY; GENE TRANSFER TECHNIQUES; LIPOSOMES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; PLASMIDS; SIMPLEXVIRUS; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

EID: 0030065719     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Anderson, W. F. Human gene therapy. Science (Washington DC), 256: 808-813, 1992.
2. Miller, A. D. Human gene therapy comes of age. Nature (Lond.), 357: 455-460, 1992.
3. Mullen, C. A., Coale, M. M., Lowe, R., and Blaese, R. M. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Cancer Res., 54: 1503-1506, 1994.
4. Gastl, G., Finstad, C., Guarini, A., Bosl, G., Gilboa, E., Bander, N., and Gansbacher, B. Retroviral vector-mediated lymphokina gene transfer into human renal cancer cells. Cancer Res., 52: 6229-6236, 1992.
5. Roth, C., Mir, L. M., and Cressent, M. Inhibition de la croissance tumorale induite par l'injection de cellules histocompatibles produisant de l'interleukine 2. C. R. Acad. Sci. Paris, 314: 499-504, 1992.
6. Nabel, G. J., Nabel, E. G. and Zhi-yong, Y. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc. Natl. Acad. Sci. USA, 90: 11307-11311, 1993.
7. Mickisch, G., Pastan, I., and Gottesman, M. Multidrug resistant transgenic mice as a novel pharmacological tool. Bioessays, 13: 381-387, 1991.
8. Colombo, M. P., Ferrari, G., and Stoppacciaro, A. Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma cells. J. Exp Med., 173: 889-897, 1991.
9. Golumbeck, P. T., Lazenby, A. J., and Levitsky, H. I. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Nature (Lond.), 254: 713-716, 1991
10. Tepper, R., Coffman, R., and Leder, P. An eosinophil-dependent mechanism for antitumor effect of interleukin 4. Science (Washington DC), 257: 548-551, 1992.
11. Temin, M. T. Retrovirus vectors: promise and reality. Science (Washington DC), 246: 983, 1989.
12. Quantin, B., Perricaudet, L., and Tagbakash, S. Adenovirus as an expression vector in muscle cells in vivo. Proc. Natl. Acad. Sci. USA, 89: 2581-2584, 1992.
13. Bett, A. J., Prevec, L., and Graham, F. L Packaging capacity and stability of human adenovirus type 5 vectors. J. Virol., 67: 5911-5921, 1993.
14. Wu, G. Y., Wilson, J. M., and Shalaby, F. Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nasase rats. J. Biol. Chem., 266: 14338-14342, 1991.
15. Stewart, M., Plautz, G., and Del Buon, L. Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. Hum. Gene Ther., 3: 267-275, 1992.
16. Colbère-Garapin, F., Chousterman, S., Horodniceanu, F., Kourilsky, P., and Garapin, A. C. Cloning of the active thyrmidine kinase gene of herpes simplex virus type 1 in Escherichia coli K-12. Proc. Natl. Acad. Sci. USA, 76: 3755-3759, 1979
17. Culver, K. W., Ram, Z., Walbridge, S., Ishii, H , Oldfield, E. H , and Blaese, R. M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science (Washington DC), 256: 1550-1552, 1992.
18. Chen, S. H., Shine, H. D., Goodman, J. C., Grossman, J. C., and Woo, S. L. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA, 91: 3054-3057, 1994
19. Ohno, T., Gordon, D., San, H., Pompili, V. J., Imperiale, M. J., Nabel, G. J., and Nabel, E. G. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science (Washington DC), 265: 781-784, 1994
20. Guzman, R. J., Hirschowitz, E. A., Brody, S. L., Crystal, R. G., Epstein, S. E., and Finkel, T. In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA, 91: 10732-10736, 1994.
21. Bi, W. L., Parysek, L. M., Warnick, R., and Stambrook, P. J. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum. Gene Ther., 4: 725-731, 1993.
22. Blaese, R. M., Culver, K. W., Ishii, H., Oldfield, E. H , Ram, Z., and Walbridge, S. Brain tumor treatment: significant contributions. Science (Washington DC), 258: 1960, 1992.
23. MacGregor, G. R., and Caskey, C. T. Construction of plasmids that express E. Coli β-galactosidase in mammalian cells. Nucleic Acids Res., 17: 2365-2367, 1989.
24. Xiang, Z., Spitalnik, S., Tran, M., Wunner, W., Cheng, J., and Ertl, H. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology, 199: 132-140, 1994.
25. Altman, D. G. Practical Statistics for Medical Research. London: Chapman and Hall, Ltd., 1991.
26. Wolff, J. A., Malone, R W., Williams, P., Chong, W., Ascadi, G., Jani, A., and Felgner, P. L. Direct gene transfer into mouse muscle in vivo. Science (Washington DC). 247: 1465-1568, 1990.
27. Freeman, S. M., Abboud, C. N., Whartenby, K. A., Packman, C. H., Koeplin, D. S., Moolten, F. L., and Abraham, G. N. The "by-stander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res., 53: 5274-5283, 1993.
28. Barba, D., Hardin, J., Ray, J., and Gage, F. H. Thymidine kinase-mediated killing of rat brain tumors. J. Neurosurg., 79: 729-735, 1993
29. Ulmer, J. B., Donnelly, J. J., Parker, S E., Rhodes, G H., Felgner, P. L., Dwarki, V. J. Gromkowski, S H., Deck, R. R., DeWitt, C. M., Friedman, A., Hawe, L. A., Leander, K. R., Martinez, D., Perry, H. C., Shiver, J. W., Montgomery, D. L., and Liu, M. A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science (Washington DC), 259: 1745-1749, 1993.
30. Oldfield, M. D., Ram, Z., Culver, K. W., Blaese, R. M., DeVroom, H. L. and Anderson, W. F. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum. Gene Ther., 4: 39-69, 1993.
31. Mulligan, R. C. The basic science of gene therapy. Science (Washington DC), 260: 926-928, 1993.
32. Mosmann, T. Rapid colorimetric assay for cellular growth and survival approach to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55-63, 1983